World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
82
Citations
25376
World Ranking
1053
National Ranking
481

Overview

Eric S. Daar is affiliated with the Lundquist Institute in the United States and has a primary focus in the field of Medicine, with extensive specialization in Infectious Diseases, Virology, Epidemiology, Neurology, and Emergency Medicine. Their research portfolio comprises 287 publications in Medicine, including 171 in Infectious Diseases and notable contributions to the study of SARS-CoV-2 and HIV/AIDS.

Daar's work covers a diverse array of topics, prominently featuring:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS Drug Development and Treatment
  • SARS-CoV-2 Detection and Testing
  • Long-Term Effects of COVID-19

Their research has been published in numerous venues, demonstrating a consistent presence in the academic community. Frequent publication venues include:

  • UNC Libraries
  • The Journal of Infectious Diseases
  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Open Forum Infectious Diseases

Eric S. Daar has collaborated frequently with a number of scientists in the field, including:

  • Kara W Chew
  • Judith S. Currier
  • Michael D. Hughes
  • Joseph J. Eron
  • David A. Wohl

Recent publications by Daar or involving their contributions include:

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women, 2021, New England Journal of Medicine
  • Clinical targeting of HIV capsid protein with a long-acting small molecule, 2020, Nature
  • Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial, 2021, The Lancet HIV
  • Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection, 2023, Annals of Internal Medicine
  • Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV, 2024, JAMA Cardiology

Best Publications

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

    Susan J. Little;Sarah Holte;Jean Pierre Routy;Eric S. Daar

  • Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.

    Eric S. Daar;Tarsem Moudgil;Richard D. Meyer;David D. Ho

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Raphael J Landovitz;Deborah Donnell;Meredith E Clement;Brett Hanscom

  • High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.

    Eric S. Daar;Xi Ling Li;Tarsem Moudgil;David D. Ho

  • Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

    Grace A. McComsey;Douglas Kitch;Eric S. Daar;Camlin Tierney

  • Modeling plasma virus concentration during primary HIV infection.

    Max A. Stafford;Lawrence Corey;Yunzhen Cao;Eric S. Daar

  • A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor

    Benjamin J. Doranz;Kathie Grovit-Ferbas;Matthew P. Sharron;Si-Hua Mao

  • Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV Infection

    Susan J. Little;Eric S. Daar;Richard T. D'Aquila;Philip H. Keiser

  • NATURALLY OCCURRING DOMINANT RESISTANCE MUTATIONS TO HEPATITIS C VIRUS PROTEASE AND POLYMERASE INHIBITORS IN TREATMENT-NAIVE PATIENTS

    Thomas Kuntzen;Joerg Timm;Andrew Berical;Niall Lennon

  • Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

    Paul E. Sax;Camlin Tierney;Ann C. Collier;Margaret A. Fischl

  • Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

    Joel Gallant;Adriano Lazzarin;Anthony Mills;Chloe Orkin

  • Diagnosis of Primary HIV-1 Infection

    Eric S. Daar;Susan Little;Jacqui Pitt;Joanne Santangelo

  • Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

    Matthew C. Strain;Susan J. Little;Eric S. Daar;Diane V. Havlir

  • Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1

    Eric S. Daar;Camlin Tierney;Margaret A. Fischl;Paul E. Sax

  • Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.

    Jarek Harezlak;Steven Buchthal;Michael Taylor;Giovanni Schifitto

  • Changes in Plasma HIV RNA Levels and CD4+ Lymphocyte Counts Predict Both Response to Antiretroviral Therapy and Therapeutic Failure

    William A. O'Brien;Pamela M. Hartigan;Eric S. Daar;Michael S. Simberkoff

  • Clinical targeting of HIV capsid protein with a long-acting small molecule.

    John O. Link;Martin S. Rhee;Winston C. Tse;Jim Zheng

  • Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.

    Ann R Falsey;Magdalena E Sobieszczyk;Ian Hirsch;Stephanie Sproule

  • Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody.

    D. D. Ho;J. A. Mckeating;Xi Ling Li;T. Moudgil

  • Antibody from Patients with Acute Human Immunodeficiency Virus (HIV) Infection Inhibits Primary Strains of HIV Type 1 in the Presence of Natural-Killer Effector Cells

    Donald N. Forthal;Gary Landucci;Eric S. Daar

  • Reduced antiretroviral drug susceptibility among patients with primary HIV infection, JAMA 282: 1142-9

    Susan J. Little;E. S. Daar;R. T. D'Aquila;P. H. Keiser

Frequent Co-Authors

Paul E. Sax
Paul E. Sax Brigham and Women's Hospital
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Susan J. Little
Susan J. Little University of California, San Diego
Richard Haubrich
Richard Haubrich University of California, San Diego
Davey M. Smith
Davey M. Smith University of California, San Diego
David W. Haas
David W. Haas Vanderbilt University Medical Center
Ann C. Collier
Ann C. Collier University of Washington
Grace A. McComsey
Grace A. McComsey Case Western Reserve University
Roy M. Gulick
Roy M. Gulick Cornell University
Ronald A. Cohen
Ronald A. Cohen University of Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can open doors to diverse career opportunities, especially for those facing unique challenges. For individuals with a past conviction, pursuing online degrees for felons offers a promising way to build a new professional path in healthcare or related fields.

For those interested in blending biology and patient care, becoming a Functional Medicine Nurse Practitioner is a growing field. Understanding the functional medicine nurse salary can help gauge financial prospects while offering a fulfilling healthcare career focused on holistic treatment.

Alternatively, career pathways in healthcare administration and data management are thriving. Becoming a Certified Professional Coder is one such option. Knowing the certified professional coder salary and related roles can guide students interested in medical billing and coding.

Health Information Management is another strategic area, combining technology with healthcare. Learning about health information management jobs salary provides insight into this in-demand field that supports clinical operations and data analytics.

Best Scientists Citing Eric S. Daar

Trending Scientists

Recently Published Articles